SCHEMBL74973

SCHEMBL74973

CCOC(=O)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.55
BCHE P06276 1/20 0.53
ALDH1A1 P00352 4/20 0.50
GAA P10253 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 3/20 0.49
APP P05067 2/20 0.49
SNCA P37840 2/20 0.49
CA12 O43570 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
ASAH1 Q13510 1/20 0.47
TSHR P16473 1/20 0.47
CTRB1 P17538 1/20 0.46
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CES1 P23141 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31241181 1.00 L3MBTL1 (0.55) L3MBTL1BCHEALDH1A1GAAKMT2A
Ethylene Glycol SCHEMBL8989789 0.95 L3MBTL1 (0.51) L3MBTL1BCHEALDH1A1GAAKMT2A
Phthalic Anhydride SCHEMBL7429661 0.92 ALDH1A1 (0.55) L3MBTL1BCHEALDH1A1GAAKMT2A
Phthalimide SCHEMBL11427744 0.90 L3MBTL1 (0.48) L3MBTL1BCHEALDH1A1GAAKMT2A
SCHEMBL14605580 0.88 L3MBTL1 (0.49) L3MBTL1BCHEALDH1A1GAAKMT2A
SCHEMBL8995177 0.87 ALDH1A1 (0.62) L3MBTL1BCHEALDH1A1GAAKMT2A
SCHEMBL5905149 0.86 BCHE (0.47) L3MBTL1BCHEALDH1A1GAAKMT2A
SCHEMBL18485418 0.84 ALDH1A1 (0.56) L3MBTL1ALDH1A1GAAKMT2AMAPT
SCHEMBL11782335 0.84 BCHE (0.58) L3MBTL1BCHEALDH1A1GAAKMT2A
SCHEMBL9395661 0.84 ALDH1A1 (0.50) L3MBTL1ALDH1A1GAAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1803 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120058554-A Epoxy curing agent containing double dynamic bonds, preparation method thereof, degradable and reconfigurable epoxy resin material and preparation method thereof 西安智聚复合材料科技有限公司 2025-05-30 CN claimed
CN-119351771-A Method for improving copper recovery rate through copper-containing dangerous waste copper regeneration smelting 江西省金瑞环保科技有限公司 2025-01-24 CN claimed
US-20240150390-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-05-09 US claimed
CN-117844214-A Flame-retardant polylactic acid resin composition and preparation method thereof 鑫双利(惠州)树脂有限公司 2024-04-09 CN claimed
WO-2024024935-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT 第一三共株式会社 2024-02-01 WO claimed
EP-4286393-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE Daiichi Sankyo Company, Limited (JP) 2023-12-06 EP claimed
CN-116867795-A Novel method for producing antibody-immunostimulant conjugate 第一三共株式会社 2023-10-10 CN claimed
CN-115634818-B Method for repairing paint by using automobile minimally invasive method 李萍 2023-08-01 CN claimed
CN-115634818-A Automobile minimally invasive repair paint repairing method 李萍 2023-01-24 CN claimed
CN-113019456-B Titanium chelate catalyst, preparation method and application thereof in silicone rubber 山东宝龙达实业集团有限公司 2022-12-30 CN claimed
US-20050272934-A1 Process for the synthesis of thalidomide ANTIBIOTICOS S.P.A. (IT) 2005-12-08 US claimed
EP-1602654-A1 Process for the synthesis of thalidomide Antibioticos S.p.A. (IT) 2005-12-07 EP claimed
US-5631360-A MULTISTAGE SYNTHESIS, TREATMENT OF NUCLEOSIDES, ADDING A N-PHTHALOYL GROUP, DEPROTECTING THE HYDROXY, TRITYLATION AND PHOSPHITYLATION RIBOZYME PHARMACEUTICALS, INC. (US) 1997-05-20 US claimed
US-5118810-A Process for preparing aldehydes from base sensitive amines MERCK & CO., INC. (US) 1992-06-02 US claimed
EP-0294818-A2 Hindered amine light stabilizers containing aromatic carboxy groups and derivatives ELF ATOCHEM NORTH AMERICA, INC. (US) 1988-12-14 EP claimed
EP-0233733-A2 Process for producing N-phthaloyl-p-nitro-L-phenylalanine KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1987-08-26 EP claimed
US-4562263-A HYPOTENSIVE AND HYDERTENSIVE AGENTS, ANTIDEPRESSANTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-12-31 US claimed
US-4535169-A 5H-6-oxo-2,3,4,4a,7,7a-hexahydropyrano[2,3-b]pyrrole and the preparation thereof THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 1985-08-13 US claimed
US-4224441-A Derivatives of 7-aminocephalosporanic acid TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1980-09-23 US claimed
US-4166178-A 3-ACYLOXYMETHYL-CEPHEM COMPOUNDS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1979-08-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150390-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE PAICS, COASY, CDS2 L3MBTL1 4350/4885BCHE 179/4885ALDH1A1 4101/4885
US-20050272934-A1 Process for the synthesis of thalidomide QPCT, GLUL, QPCTL L3MBTL1 4030/4885BCHE 3078/4885ALDH1A1 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.